Prilocaine

Prilocaine
Prilocaine
Systematic (IUPAC) name
(RS)-N-(2-methylphenyl)-N2-propylalaninamide
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a603026
Pregnancy cat. B (U.S.)
Legal status  ?
Pharmacokinetic data
Protein binding 55%
Metabolism Hepatic and renal
Half-life 10-150 minutes, longer with impaired hepatic or renal function
Identifiers
CAS number 721-50-6 YesY
ATC code N01BB04
PubChem CID 4906
DrugBank APRD00180
ChemSpider 4737 YesY
UNII 046O35D44R YesY
KEGG D00553 YesY
ChEBI CHEBI:8404 N
ChEMBL CHEMBL1194 YesY
Chemical data
Formula C13H20N2O 
Mol. mass 220.311 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Prilocaine (pronounced /ˈpraɪlɵkeɪn/) is a local anesthetic of the amino amide type first prepared by Claes Tegner and Nils Lofgren. In its injectable form (trade name Citanest), it is often used in dentistry. It is also often combined with lidocaine as a preparation for dermal anesthesia (lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia. As it has low cardiac toxicity, it is commoly used for intravenous regional anaesthesia (IVRA).

In some patients, a metabolite of prilocaine may cause the unusual side effect of methemoglobinemia, which may be treated with methylene blue.

Maximum dosage for dental use: 8.0 mg/kg (2.7 mg/lb), with a maximum dose of 500 mg.

It is given as a combination with the vasoconstrictor epinephrine under the trade name Citanest Forte.

Compendial status

Notes

See also